Cargando…

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

This nationwide, population-based study aimed to clarify the effects of immunosuppressive regimens on new-onset diabetes after liver transplantation (NODALT). The National Health Insurance database of Taiwan was explored for patients who received liver transplantation without pre-transplant diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fu-Chao, Lin, Huan-Tang, Lin, Jr-Rung, Yu, Huang-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571855/ https://www.ncbi.nlm.nih.gov/pubmed/28860788 http://dx.doi.org/10.2147/TCRM.S142348

Ejemplares similares

Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation
por: Liu, Fu-Chao, et al.
Publicado: (2017)

Prevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: A population-based cohort study
por: Liu, Fu-Chao, et al.
Publicado: (2016)

Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study
por: Chen, Hsiu-Pin, et al.
Publicado: (2016)

Impact of the pretransplant dialysis modality on kidney transplantation outcomes: a nationwide cohort study
por: Lin, Huan-Tang, et al.
Publicado: (2018)

Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients
por: Tsai, Yung Fong, et al.
Publicado: (2016)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study
por: Chung, Peter Chi-Ho, et al.
Publicado: (2016)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy
por: Chaitou, Ali R, et al.
Publicado: (2022)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Population-Based Cohort Study
por: Tsai, Yung-Fong, et al.
Publicado: (2021)

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021)

Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study
por: Tsai, Yung-Fong, et al.
Publicado: (2018)

Abstract 132: Incidence and predictors of new onset diabetes after transplant (NODAT) in liver transplant recipients
por: Sheth, Kaushal V, et al.
Publicado: (2022)

PSUN228 Incidence and Predictors of New Onset Diabetes After Transplant (NODAT) in Liver Transplant recipients.
por: Sheth, Kaushal, et al.
Publicado: (2022)

The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study
por: Cheng, Chih-Wen, et al.
Publicado: (2016)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016)

Incidence and Outcomes of Acute Renal Failure Following Liver Transplantation: A Population-Based Cohort Study
por: Chen, Hsiu-Pin, et al.
Publicado: (2015)

Massive Necrotizing Pancreatitis in an Immunosuppressed Renal Transplant Recipient (Successful Therapy)
por: Slaton, Joel W., et al.
Publicado: (1993)

COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
por: Kolla, Epiphane, et al.
Publicado: (2023)

Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis
por: Kotha, Sreelakshmi, et al.
Publicado: (2021)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
por: Albekairy, Abdulkareem M., et al.
Publicado: (2018)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients
por: Aguiar, Diego, et al.
Publicado: (2017)

“SARS-CoV-2 Infection in Liver Transplant Recipients - Immunosuppression is the Silver Lining?”
por: Jadaun, Shekhar S., et al.
Publicado: (2022)

Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
por: Gu, Guangxiang, et al.
Publicado: (2023)

Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review
por: Zhu, Yichen, et al.
Publicado: (2017)

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients
por: Filipov, Jean Jeanov, et al.
Publicado: (2015)

Factors Associated With Adherence To Immunosuppressive Therapy And Barriers In Asian Kidney Transplant Recipients
por: Ganjali, Raheleh, et al.
Publicado: (2019)

Impact of metabolic syndrome on quality of life of liver transplant recipients
por: Wang, Zhenshun, et al.
Publicado: (2018)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
por: Brodosi, Lucia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emqgff1r0ne5kifkkfi0dtp7r0